首页> 外国专利> New N-substituted oxazolidine derivatives useful for preparing hydroxyalkylamino and polymeric hydroxyalkylamino derivatives for manufacturing e.g. high-performance composite materials for parts of automotives and electronics

New N-substituted oxazolidine derivatives useful for preparing hydroxyalkylamino and polymeric hydroxyalkylamino derivatives for manufacturing e.g. high-performance composite materials for parts of automotives and electronics

机译:可用于制备羟烷基氨基的新的N-取代的恶唑烷衍生物和用于制造例如丙二醛的聚合的羟烷基氨基衍生物。用于汽车和电子零件的高性能复合材料

摘要

N-Substituted oxazolidine derivatives (I) are new. N-Substituted oxazolidine derivatives of formula (I) are new. R3 : -H, -1-8C alkyl or 6-15C aryl; R6 : CH 2-CHR1-O-CO-1-8C-alkyl, -CH 2-CHR1-O-CO-CR5=CH 2, -CH 2-CHR1-O-CO-NH-1-8C-alkyl, -CH 2-CHR1-O-CO-NH-6-15C-aryl, -CO-O-1-8C-alkyl, -CO-CR5=CH 2, -CO-O-phenyl, -CO-NH-1-8C-alkyl, -CO-NH-6-15C-aryl, -CH 2-CHR1-O-CO-CH 2-CO-CH 3, -CH 2-CHR1-O-CO-CH 2-CO-O-1-12C-alkyl; and R1, R5 : 1-8C alkyl or H. Independent claims are included for: (1) the preparation of (I); (2) hydroxyalkylamino derivatives of formula (Y1-[A] m) (III); (3) the preparation of (III) comprising (d) reacting the N-substituted oxazolidine derivative with a compound (A) comprising urea, di-alkylurea, triazines such as melamine, melam, substituted melamine, preferably succinimidomelamine, phthalimidomelamine, alkylated melamine (preferably N,N-dimethylmelamine) or ammeline, guanamines such as benzoguanamine or acetoguanamine, and amides, preferably bi- or polyfunctional polyamides, polyureas and polyurethanes and phenols, preferably ortho- or para-substituted phenols, bisphenol and novolac, preferably novolac from ortho- or para-substituted phenols; (4) N-substituted bisoxazolidine derivatives of formula (IV); (5) the preparation of (IV) comprising (a) reacting alkanolamine compounds of formula (HN-(CH 2CHR1-OH) 2) (A) or (HNR2-CH 2-CHR1-OH) (B) with an aldehyde of formula (HC(R3)=O); (b) dehydrating formed methylol derivatives to give an oxazolidine derivative of formula (II); and (c1) reacting (II) with bifunctional compounds containing bifunctional dicarboxylic groups of formula (1-4C alkyl-O-CO-1-8C alkyl-CO-O-1-4C alkyl), (1-4C alkyl-O-CO-6-15C-aryl-CO-O-1-4C alkyl), (1-4C alkyl-O-CO-CH=CH-CO-O-1-4 alkyl) or their anhydrides, diisocyanates of formula (OCN-1-8C alkyl-NCO) or (OCN-6-15C-aryl-NCO), or organic carbonates of formula (1-4C alkyl-O-CO-O-1-4C alkyl), (1-4C alkyl-O-CO-O-phenyl), (phenyl-O-CO-O-phenyl) to give (IV); (6) polymeric hydroxyalkylamino derivatives of formula ([-Y1-B1-] p) (XIII); (7) the preparation of (XIII) comprising (d1) reacting the N-substituted bisoxazolidine derivative with a compound (A), where the amide is preferably polyamides, polyureas and polyurethanes; (8) a mixture comprising at least one derivative (III) and/or at least a derivative (XIII) and at least one additive comprising UV stabilizers in the form of radical stabilizers and/or UV absorbers, fillers, reinforcing fibers and/or radical initiators; and (9) the use of (III) and/or (XIII) and the mixture for manufacturing crosslinked semifinished products, molding materials or high-performance composite materials for highly stressed parts in automotives, mechanical engineering, electrical engineering and electronics. In formula (III), A : -CHR3-NR15-CH 2-CHR1-OR16; Y1 : hydroxy phenyl group of formula (a)-(d), triazine group of formula (e)-(h), (-N12-CO-NR12) (i), ((-C(O)-NX-R8-) m) (j), ((-O-C(O)-NX-R8-) m) (k) or ((-NX-C(O)-NX-R8-) m) (l); R1, R3, R5 : 1-8C alkyl or H; R8 : 1-8C alkyl or 6-15C-aryl; R10 : 1-3C-alkyl; R11 : H, 1-4C alkyl, C 6H 5, C 6H 4-OH or 1-3C-alkyl-C 6H 4OH; R12 : H, 1-4C alkyl, 6-15C-aryl or -CHR3-NR15-CH 2CHR1-OR16; R13 : 1-8C alkyl, C 6H 5or heterocyclic groups (A13) comprising pyrrolidine-2,5-dion-1-yl group of formula (m), pyrrolidine-2,5-dion-1-yl, 3-methylene-pyrrolidine-2,5-dion-1-yl, piperidine-2,6-dion-1-yl, hexahydro-isoindole-1,3-dion-2-yl, decahydro-benzo[f]isoindole-1,3-dion-2-yl, isoindole-1,3-dion-2-yl or benzo[f]isoindole-1,3-dion-2-yl; R14 : 1-8C alkyl or 6-15C-aryl; R15 : H, 1-4C alkyl, 6-15C-aryl or -CH 2-CHR1-OR16; R16 : H, 1-8C-alkyl, -CO-NH-(1-18C alkyl), -CO-CR5=CH 2, -CO-O-1-4C alkyl, -CO-O-6-15C-aryl, -CO-CH 2-CO-CH 3, -CO-CH 2-CO-O-(1-12C-alkyl) or -Si(1-8C alkyl) 3; R17 : 1-12C-alkyl or -CH=CH-1-10C alkyl; X : A or H; and m, o : 1-30, where the linkage between the units A and Y1 takes place by at least one N atom, when Y1 unit contains a N-atom substituent, the linkage is in ortho and/or para-position to the hydroxyl group of the hydroxyaromatics, when the Y1 unit includes a hydroxyaromatic substitute in these positions, and/or the linkage between the units A and Y1 takes place by at least one O atom, when Y1 unit contains a O-atom substituent. In formula (IV), R3 : -H, -1-8C alkyl or 6-15C aryl; R1 : 1-8C alkyl or H; R7 : CH 2-CHR1-O-CO-R8-C(O)-O-CHR1-CH 2-, -CH 2-CHR1-O-CO-O-CHR1-CH 2-, -CH 2-CHR1-O-CO-NH-R8-NH-CO-O-CHR1-CH 2-, -C(O)-, -C(O)-R8-C(O)-, -C(O)-NH-R8-NH-C(O)- or -1-8C-alkyl; and R8 : 1-8C alkyl, 6-15C aryl or -CH=CH-. In formula (A), (B) and (II), R1 : H or 1-8C alkyl; R2, R3 : H, 1-8C-alkyl or 6-15C-aryl; and R4 : H, 1-8C alkyl, 6-15C-aryl or CH 2-CHR1-OH. In formula (XIII), B1 : CHR3NR15-CH 2-CHR1-O-CO-R9-CO-O-CHR1-CH 2-NR15-CHR3, -CHR3-NR15-CH 2-CHR1-O-CO-NH-R9-NH-CO-O-CHR1-CH 2-NR15-CHR3, -CHR3-N(CH 2-CHR1-OR16)-CO-N(CH 2-CHR1-OR16)-CHR3- or -CHR3-N(CH2-CHR1-OR16)-R2-N(CH2-CHR1-OR16)-CHR3-; Y1 : groups (b)-(l); R1, R5 : 1-8C alkyl or H; R8, R9 : 1-8C alkyl or 6-15C-aryl; R11 : -H, -1-4C alkyl, -C 6H 5or -1-3C-alkyl-C 6H 4OH; R3, R12 : -H, -1-4C alkyl or -6-15C-aryl; R13 : 1-8C alkyl, -C 6H 5or heterocyclic groups (A13); R15 : H, 1-4C alkyl, -6-15C-aryl or -CH 2-CHR1-OR16; R16 : H, -1-8C-alkyl, -CO-NH-(1-18C alkyl), -CO-CR5=CH 2, -CO-O-1-4C alkyl, -CO-O-6-15C-aryl, -CO-CH 2-CO-CH 3, -CO-CH 2-CO-O-(1-12C-alkyl) or -Si(1-8C alkyl) 3; R17 : 1-12C-alkyl or -CH=CH-1-10C alkyl; X : A or H; m, o : 1-30; and p : 3-100, where the linkage between the units A and Y1 takes place by at least one nitrogen atom, when Y1 unit contains a N-atom substituent, the linkage is in ortho and/or para-position to the hydroxyl group of the hydroxyaromatics, when the Y1 unit includes a hydroxyaromatic substitute in these positions, and/or the linkage between the units A and Y1 takes place by at least one O atom, when Y1 unit contains a O-atom substituent. [Image] [Image] [Image] [Image] [Image].
机译:N-取代的恶唑烷衍生物(I)是新的。式(I)的N-取代的恶唑烷衍生物是新的。 R3:-H,-1-8C烷基或6-15C芳基; R6:CH 2 -CHR 1 -O-CO-1-8C-烷基,-CH 2 -CHR 1 -O-CO-CR 5 = CH 2 -CH 2 -CHR1-O-CO-NH-1-8C-烷基, -CH 2-CHR1-O-CO-NH-6-15C-芳基,-CO-O-1-8C-烷基,-CO-CR5 = CH 2,-CO-O-苯基,-CO-NH-1 -8C-烷基,-CO-NH-6-15C-芳基,-CH 2-CHR1-O-CO-CH 2-CO-CH 3,-CH 2-CHR1-O-CO-CH 2-CO-O -1-12C-烷基;独立的权利要求包括:(1)制备(I);和R 1,R 5:1-8C烷基或H。 (2)式(Y1- [A] m)(III)的羟烷基氨基衍生物; (3)(III)的制备,包括(d)使N-取代的恶唑烷衍生物与包含尿素,二烷基脲,三嗪例如三聚氰胺,三聚氰胺,取代的三聚氰胺,优选为琥珀酰亚胺二甲胺,邻苯二甲四胺,烷基化三聚氰胺的化合物(A)反应。 (优选N,N-二甲基三聚氰胺)或氨苯胺,胍胺(例如苯并胍胺或乙酰胍胺)和酰胺,优选双或多官能聚酰胺,聚脲和聚氨酯和酚,优选邻位或对位取代的酚,双酚和酚醛清漆,优选酚醛清漆邻或对位取代的酚; (4)式(IV)的N-取代的双恶唑烷衍生物; (5)(IV)的制备,包括(a)使式(HN-(CH 2CHR1-OH)2)(A)或(HNR2-CH 2-CHR1-OH)(B)的链烷醇胺化合物与醛式(HC(R 3)= O); (b)使形成的羟甲基衍生物脱水,得到式(II)的恶唑烷衍生物; (c1)使(II)与含有式(1-4C烷基-O-CO-1-8C烷基-CO-O-1-4C烷基)的双官能二羧酸基的双官能化合物反应,(1-4C烷基-O- CO-6-15C-芳基-CO-O-1-4C烷基),(1-4C烷基-O-CO-CH = CH-CO-O-1-4烷基)或它们的酸酐,式(OCN -1-8C烷基-NCO)或(OCN-6-15C-芳基-NCO)或式(1-4C烷基-O-CO-O-1-4C烷基),(1-4C烷基- O-CO-O-苯基),(苯基-O-CO-O-苯基)得到(IV); (6)式([-Y1-B1-] p)(XIII)的聚合的羟烷基氨基衍生物; (7)(XⅢ)的制备方法,包括(d1)使N-取代的双恶唑烷衍生物与化合物(A)反应,其中酰胺最好是聚酰胺,聚脲和聚氨酯。 (8)包含至少一种衍生物(III)和/或至少一种衍生物(XIII)和至少一种添加剂的混合物,所述添加剂包含自由基稳定剂形式的UV稳定剂和/或UV吸收剂,填料,增强纤维和/或自由基引发剂; (9)(III)和/或(XIII)及其混合物在汽车,机械工程,电气工程和电子产品中用于制造高应力零件的交联半成品,模塑材料或高性能复合材料的用途。式(III)中,A:-CHR 3 -NR 15 -CH 2 -CHR 1 -OR 16。 Y1:式(a)-(d)的羟基苯基,式(e)-(h)的三嗪基,(-N12-CO-NR12)(i),((-C(O)-NX-R8 -)m)(j),((-OC(O)-NX-R8-)m)(k)或((--NX-C(O)-NX-R8-)m)(l); R1,R3,R5:1-8C烷基或H; R8:1-8C烷基或6-15C-芳基; R10:1-3C-烷基; R11:H,1-4C烷基,C 6H 5,C 6H 4-OH或1-3C-烷基-C 6H 4OH; R12:H,1-4C烷基,6-15C芳基或-CHR3-NR15-CH 2CHR1-OR16; R13:1-8C烷基,C 6H 5或包含式(m)的吡咯烷-2,5-二价-1-基,吡咯烷-2,5-二价-1-基,3-亚甲基-的杂环基(A13)吡咯烷-2,5-二价-1-基,哌啶-2,6-二价-1-基,六氢-异吲哚-1,3-二价-2-基,十氢-苯并[f]异吲哚-1,3-二on-2-基,异吲哚-1,3-dion-2-基或苯并[f]异吲哚-1,3-dion-2-基; R14:1-8C烷基或6-15C-芳基; R15:H,1-4C烷基,6-15C芳基或-CH 2 -CHR1-OR16; R16:H,1-8C-烷基,-CO-NH-(1-18C烷基),-CO-CR5 = CH 2,-CO-O-1-4C烷基,-CO-O-6-15C-芳基,-CO-CH 2 -CO-CH 3,-CO-CH 2 -CO-O-(1-12C-烷基)或-Si(1-8C烷基)3; R17:1-12C-烷基或-CH = CH-1-10C烷基; X:A或H; m,o:1-30,其中单元A和Y1之间的连接是通过至少一个N原子发生的,当Y1单元包含一个N原子取代基时,该连接是在该单元的邻位和/或对位。当Y 1单元在这些位置上包含羟基芳族取代基时,和/或当Y 1单元包含O原子取代基时,单元A和Y 1之间的键合通过至少一个O原子发生。在式(IV)中,R 3:-H,-1-8C烷基或6-15C芳基; R1:1-8C烷基或H; R7:CH 2-CHR1-O-CO-R8-C(O)-O-CHR1-CH 2-,-CH 2-CHR1-O-CO-O-CHR1-CH 2-,-CH 2-CHR1- O-CO-NH-R8-NH-CO-O-CHR1-CH 2-,-C(O)-,-C(O)-R8-C(O)-,-C(O)-NH-R8 -NH-C(O)-或-1-8C-烷基; R 8:1-8C烷基,6-15C芳基或-CH = CH-。在式(A),(B)和(II)中,R 1:H或1-8C烷基; R2,R3:H,1-8C-烷基或6-15C-芳基; R4:H,1-8C烷基,6-15C-芳基或CH 2 -CHR1-OH。式(XIII)中,B 1:CHR 3 NR 15 -CH 2 -CHR 1 -O-CO-R 9 -CO-O-CHR 1 -CH 2 -NR 15 -CHR 3,-CHR 3 -NR 15 -CH 2 -CHR 1 -O-CO-NH- R9-NH-CO-O-CHR1-CH 2-NR15-CHR3,-CHR3-N(CH 2-CHR1-OR16)-CO-N(CH 2-CHR1-OR16)-CHR3-或-CHR3-N( CH2-CHR1-OR16)-R2-N(CH2-CHR1-OR16)-CHR3-; Y1:(b)-(l)组; R1R 5:1-8C烷基或H; R8,R9:1-8C烷基或6-15C-芳基; R11:-H,-1-4C烷基,-C 6H 5或-1-3C-烷基-C 6H 4OH; R3,R12:-H,-1-4C烷基或-6-15C-芳基; R13:1-8C烷基,-C 6H 5或杂环基(A13); R15:H,1-4C烷基,-6-15C-芳基或-CH 2 -CHR1-OR16; R16:H,-1-8C-烷基,-CO-NH-(1-18C烷基),-CO-CR5 = CH 2,-CO-O-1-4C烷基,-CO-O-6-15C-芳基,-CO-CH 2 -CO-CH 3,-CO-CH 2 -CO-O-(1-12C-烷基)或-Si(1-8C烷基)3; R17:1-12C-烷基或-CH = CH-1-10C烷基; X:A或H; m,o:1-30; m:1-30。和p:3-100,其中单元A和Y1之间的连接是通过至少一个氮原子发生的,当Y1单元包含一个N原子取代基时,该连接是在羟基的邻位和/或对位当Y 1单元在这些位置上包含羟基芳族取代基时,和/或当Y 1单元包含O原子取代基时,单元A和Y 1之间的键合通过至少一个O原子发生。 [图像] [图像] [图像] [图像] [图像]。

著录项

  • 公开/公告号DE102008038941A1

    专利类型

  • 公开/公告日2010-02-18

    原文格式PDF

  • 申请/专利权人 BOREALIS AGROLINZ MELAMINE GMBH;

    申请/专利号DE20081038941

  • 发明设计人 RAETZSCH MANFRED;MEINECKE ANDREAS;

    申请日2008-08-11

  • 分类号C07D263/04;C08G12/00;C08J5/24;

  • 国家 DE

  • 入库时间 2022-08-21 18:28:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号